|
Alembic Pharmaceuticals receives USFDA approval for Levothyroxine Sodium Tablets> |
|
Alembic Pharma gains after Q4 PAT climbs 29% YoY to Rs 203 cr> |
|
Board of Alembic Pharmaceuticals recommends final dividend> |
|
Alembic Pharmaceuticals consolidated net profit rises 29.20% in the March 2026 quarter> |
|
Alembic Pharma gains after receiving USFDA nod for Darolutamide tablets> |
|
Alembic Pharmaceuticals receives USFDA approval for Darolutamide Tablets, 300 mg> |
|
Alembic Pharmaceuticals' Karakhadi unit completes USFDA inspection> |
|
Alembic Pharmaceuticals to discuss results & dividend> |
|
Alembic Pharmaceuticals receives USFDA approval for Fingolimod Capsules> |
|
Alembic Pharma gains after incorporating subsidiary in Philippines> |